Our expertise
  • Tailored services
  • How to collaborate with us
  • IP policy and confidentiality
  • European projects
News & more
  • News
  • Events
  • Blog
About us
  • Awards and Certifications
  • History and Start-ups
  • Governance
  • Annual Reports
Working at CSEM
  • Jobs
  • Back2Business program
  • ACCELERATE start-up program
Press and Publications
  • Press room
  • Downloads
  • YODA Open access platform
Contact
  • Our expertise
    • Technical focus
      • Additive manufacturing
      • ASICs for the edge
      • Batteries
      • Data and AI
      • Digital energy
      • Digital health
      • Functional surfaces
      • Industry 4.0
      • Integrated and lightweight photovoltaics
      • IoT and vision
      • MEMS
      • Photonics
      • Quantum technologies
      • Scientific instruments
      • Solar cells and modules
      • Tools for life sciences
    • Industrial focus
      • Automotive and transportation
      • Consumer electronics
      • Energy
      • Environment
      • Food and agriculture
      • Healthcare, wellness and sport
      • Industrial automation
      • Information and Communication Technologies
      • Life sciences
      • Security and safety
      • Semiconductors
      • Smart home and building
      • Space and aeronautics
      • Watchmaking
    • Tailored services
    • How to collaborate with us
    • IP policy and confidentiality
    • European projects
  • News & more
    • News
    • Events
    • Blog
  • About us
    • Awards and Certifications
    • History and Start-ups
    • Governance
    • Annual Reports
  • Working at CSEM
    • Jobs
    • Back2Business program
    • ACCELERATE start-up program
  • Press and Publications
    • Press room
    • Downloads
    • YODA Open access platform
  • Contact
HomepagePress and PublicationsPressORGANTRANS
February 4, 2020

ORGANTRANS

European (EU) H2020 funded ORGANTRANS project is set to develop a disruptive solution that enables the 3D printing of tissue-engineered constructs. Coordinated by CSEM, eight consortium members will create a standardized and automated tissue preparation and maturation platform, which will provide patients with End-Stage Liver Disease (ESLD) an alternative to donor organ transplants.

Organtrans - new regenerative therapy
Press release

Related Press

A hand holding a bioreactor to grow vein grafts developed by CSEM and ClexBio

22 February 2024

CSEM and ClexBio create a bioreactor for tissue-engineered cardiovascular implants

The teams at CSEM and at ClexBio have developed a process for engineering vein grafts comprised of human tissue material that integrates into the patient’s body and can turn into real, living tissue....

(Left to Right) A. Schueller, Founder and CEO; This Egloff, Scientist (cellvie); Charlotte Fonta, Senior R&D Engineer; and Gilles Weder, Head R&BD, Life Science Technologies, CSEM.

3 September 2025

Breakthrough in mitochondria therapy: CSEM and cellvie automate isolation process for clinical use

cellvie and CSEM are advancing an automated solution to standardize mitochondrial therapy manufacturing, accelerating treatment for ischemia-reperfusion injury and potentially helping over 3 million p...

Limula team

3 February 2023

Making personalized cancer therapies accessible to all

CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments. ...

CSEM SA, Rue Jaquet-Droz 1, 2000 Neuchâtel

© 2026 CSEM SA

Legal noticePrivacy policyCookie policy